Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure (Q38379557)

2 September 2017

Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

Philipp Badorrek

1

1 reference

2 September 2017

Meike Müller

2

1 reference

2 September 2017

Wolfgang Koch

3

1 reference

2 September 2017

Jens M Hohlfeld

4

1 reference

2 September 2017

Norbert Krug

5

1 reference

2 September 2017

1 March 2017

1 reference

Annals of Allergy, Asthma & Immunology

2 September 2017

1 reference

2 September 2017

118

1 reference

2 September 2017

3

1 reference

2 September 2017

290-297

1 reference

Current and future biomarkers in allergic asthma

2 September 2017

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU)

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Measuring nasal nitric oxide in allergic rhinitis patients.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: A cross-sectional study in bronchial asthma and allergic rhinitis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Development of a new technique for recovery of cytokines from inflammatory sites in situ

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Cytokine profiles in nasal fluid of patients with seasonal or persistent allergic rhinitis.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

The kinetics of allergen-induced eotaxin level in nasal lavage fluid: its key role in eosinophil recruitment in nasal mucosa

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Nasal nitric oxide is dependent on sinus obstruction in allergic rhinitis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Controlled Allergen Challenge Facilities and Their Unique Contributions to Allergic Rhinitis Research

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Allergen Challenge Chamber: an innovative solution in allergic rhinitis diagnosis

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.ANAI.2017.01.018

Identifiers

DOI

10.1016/J.ANAI.2017.01.018

1 reference

2 September 2017

1 reference